Background
The AODTS–NMDS was implemented to help monitor and evaluate key objectives of the National Drug Strategic Framework 1998–99 to 2003–04 and to help plan, manage and improve the quality of alcohol and other drug treatment services (see AIHW: Grant & Petrie 2001 for historical development of the AODTS–NMDS). The AODTS–NMDS will continue to support the National Drug Strategy 2004–09, particularly as trend data are becoming available.
Since 1985, Australia’s drug strategies have been based on the principle of minimising harm caused by licit drugs, illicit drugs and other substances. The principle of harm minimisation incorporates strategies to reduce drug-related harm to individuals and communities as well as supply and demand reduction strategies. No single data collection can provide all of the information relating to national treatment objectives. This report therefore also presents information from a range of other data sources to provide context to the AODTS–NMDS data and present a more complete picture of the current state of alcohol and other drug treatment services in Australia today (see Chapter 7).
The data presented in this report, in conjunction with other information sources, can be used to inform issues of access to treatment services and more generally to inform debate, policy decisions and planning processes that occur within the alcohol and other drug treatment sector.
Preliminary material: List of tables; List of figures; List of boxes; Acknowledgments; Abbreviations; Highlights
-
Introduction
- Background
- Collection method and data included
- Scope of the AODTS-NMDS
- Counts in the collection
- Features of the 2004-05 collection
- Outputs from the AODTS-NMDS collection
- Recent drug use
-
Treatment agency profile
- Establishment sector
- Location of treatment agencies
-
Client profile
- Closed treatment episodes and client registrations
- Client type and jurisdictions
- Age and sex
- Indigenous status
- Country of birth and preferred language
-
Drugs of concern
- Jurisdictions and principal drug of concern
- Sex, age and principal drug of concern
- Country of birth and principal drug of concern
- Indigenous status and principal drug of concern
- Geographic location and principal drug of concern
- Source of referral and principal drug of concern
- Other drugs of concern
- Injecting drug use and principal drug of concern
- Method of use and principal drug of concern
- Reason for cessation and principal drug of concern
-
Treatment programs
- Jurisdictions and treatment programs
- Main treatment for selected principal drugs
- Client type, source of referral and treatment programs
- Sex, age and treatment program
- Indigenous status and treatment program
- Geographic location and treatment program
- Additional treatments
- Reason for cessation and treatment program
- Treatment delivery setting and treatment program
-
Special theme: cannabis
- Introduction
- Client profile
- Treatment programs
-
Other data collections
- Background
- Monitoring alcohol and other drug problems
- Use, mortality and morbidity data
- National pharmacotherapy statistics
- Alcohol and other drug treatment services provided by services funded to
assist Aboriginal and Torres Strait Islander peoples
-
Data quality of the AODTS-NMDS in 2004-05
- Introduction
- Data quality
- Data transmission
Appendixes
- Appendix 1: Data elements included in the AODTS-NMDS for 2004-05
- Appendix 2: Policy and administrative features in each jurisdiction
- Appendix 3: Technical notes
- Appendix 4: Detailed tables
- Appendix 5: AODTS-NMDS treatment types
- Appendix 6: Australian Standard Geographical Classification
- Appendix 7: Australian Standard Classification of Drugs of Concern (ASCDC)
End matter: References